株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ゲノミクスの世界市場分析:製品タイプ別 (DNAマイクロアレイ、シーケンサー、PCR)、サービス別 (バイオインフォマティクス、DNA試料シーケンシング、デノボ、SNPS、遺伝子発現)

Genomics Market: Product Types ; By Services ; By End-User ; By Geography - 2019-2024

発行 IndustryARC 商品コード 351122
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
ゲノミクスの世界市場分析:製品タイプ別 (DNAマイクロアレイ、シーケンサー、PCR)、サービス別 (バイオインフォマティクス、DNA試料シーケンシング、デノボ、SNPS、遺伝子発現) Genomics Market: Product Types ; By Services ; By End-User ; By Geography - 2019-2024
出版日: 2018年12月01日 ページ情報: 英文
概要

当レポートでは、世界のゲノミクス市場の現状と今後の市場成長見通し、製品タイプ別、サービス別動向、地域別分析とともに、市場に参入する主要企業のプロファイルをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市況

  • 市場シェア分析
  • 競合分析
    • 製品ベンチマーキング
    • エンドユーザープロファイリング
    • 特許分析
    • 上位5社財務分析

第4章 市場の力

  • 市場促進因子
  • 市場抑制力
  • 市場の課題
  • 同業界の魅力

第5章 戦略的分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品ライフサイクル
  • サプライヤーおよび販売業者

第6章 製品タイプ別

  • イントロダクション
  • 製品
    • DNAマイクロアレイ
    • 電気泳動
    • X線結晶学
    • ポリメラーゼ連鎖反応 (PCR)
    • DNAシーケンサー
    • クロマトグラフィー
  • 用いられる試薬

第7章 サービス業界分析

  • イントロダクション
  • バイオインフォマティクスデータベース
  • バイオインフォマティクスツール
  • ラボサービスー
    • DNA試料シーケンシング
    • デノボシーケンシング
    • 標的再シーケンシング
    • 個別ゲノムシーケンシング
    • SNPS解析
    • 分子生物学
    • 遺伝子発現分析
    • 遺伝子型決定サービス
    • バイオマーカーソリューション

第8章 エンドユーザー応用分析

  • イントロダクション
  • 人類学
  • 農業
  • 細胞遺伝学
  • 診断
  • 創薬
  • 毒性ゲノミクス
  • その他

第9章 地域別分析

  • イントロダクション
  • 南北アメリカ
  • 欧州
  • アジア太平洋地域
  • その他

第10章 市場エントロピー

第11章 投資の機会

第12章 企業レポート

第13章 付録

目次

"Global Genomic Market Overview:

A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 10.2% during the forecast period of 2019 to 2025.

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI. It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7% - 10%a€‰annually throughout 2020, with universal oncology cost exceeding $150a€‰billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

Global Genomics Market Players Perspective:

Some of other key players profiled in this IndustryARC business intelligence report are Beckton Dickson, Synthetic Genomics Inc. (SGI) ,Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc., Danaher Corporation,F. Hoffmann-La Roche, QIAGEN, Thermo Fisher Scientific and PacBio (Pacific Biosciences of California). Majority of the companies mentioned are situated in North America augmenting the regional affluence in the global market.

Global Genomics Market Trends:

High overload owing to a wide range of reagents and consumables has propelled companies into approving different policies to endure in the market and stay ahead of the curve.

For instance, in January 2017, BD launched Precise WTA Reagents for precise and guileless quantification of hereditary data form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR International, an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe.

Genomics Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Genomics Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of equipment in the Genomics Market, and their specific applications in different phases of industrial operations.

Genomics Market Report: Industry Coverage

Types of Solutions Genomics Market:

By Product Types- Microarray chip, Sequencers.By Application- Genotyping, SNP analysis.By End-User- Anthropology, Diagnostics.

The Genomics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Reference:

[1]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812392/[2]https://www.who.int/en/news-room/fact-sheets/detail/cancer[3]http://www.fao.org/3/y4252e/y4252e06a.htm"

1. Global Genomics Market Overview

2. Executive Summary

3. Global Genomics Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End user profiling
    • 3.2.3. Patent Analysis
    • 3.2.4. Top 5 Financials Analysis

4. Global Genomics Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Genomics Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Genomics Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Global Genomics Market - Product Types Analysis

  • 6.1. Introduction
  • 6.2. Products
    • 6.2.1. DNA Microarrays
    • 6.2.2. Electrophoresis
    • 6.2.3. X-Ray Crystallography
    • 6.2.4. Polymerase Chain Reaction (PCR)
    • 6.2.5. DNA Sequencers
      • 6.2.5.1. 1st Generation
      • 6.2.5.2. 2nd Generation
      • 6.2.5.3. 3rd Generation
      • 6.2.5.4. Next Generation
    • 6.2.6. Chromotography
  • 6.3. Reagents Used

7. Global Genomics Market - Service Industry Analysis

  • 7.1. Introduction
  • 7.2. Bio-informatics Database
  • 7.3. Bio-informatics Tools
  • 7.4. Laboratory Services
    • 7.4.1. DNA Sample Sequencing
    • 7.4.2. De Novo Sequencing
    • 7.4.3. Targeted Re-sequencing
    • 7.4.4. Individual Genome Sequencing
    • 7.4.5. SNPS Analysis
    • 7.4.6. Molecular Biology
    • 7.4.7. Gene Expression Analysis
    • 7.4.8. Genotyping Service
    • 7.4.9. Biomarker Solutions

8. Global Genomics Market - End Use Applications Analysis

  • 8.1. Introduction
  • 8.2. Anthropology
  • 8.3. Agriculture
  • 8.4. Cytogenetics
  • 8.5. Diagnostics
  • 8.6. Drug Discovery
  • 8.7. Toxicogenomics
  • 8.8. Others

9. Global Genomics Market - Geographic Analysis

  • 9.1. Introduction
  • 9.2. Americas
    • 9.2.1. North America
    • 9.2.2. Brazil
    • 9.2.3. Argentina
    • 9.2.4. Mexico
  • 9.3. Europe
    • 9.3.1. UK
    • 9.3.2. France
    • 9.3.3. Germany
  • 9.4. APAC
    • 9.4.1. China
    • 9.4.2. South Korea
    • 9.4.3. Japan
    • 9.4.4. Australia
  • 9.5. ROW

10. Market Entropy

  • 10.1. New Product Launches
  • 10.2. M&As, Collaborations, JVs and Partnerships

11. Investment Opportunities - Analysis by Target companies/customers, Capital Investments, ROI, Payback Period and Source of Funds.

12. Company Reports (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 12.1. Affymetrix
  • 12.2. Agilent Technologies
  • 12.3. Applied Biosystems Group
  • 12.4. Bayer AG
  • 12.5. Bio-Rad Laboratories
  • 12.6. Caliper Life Sciences
  • 12.7. Cepheid
  • 12.8. Complete Genomics
  • 12.9. Existence Genetics
  • 12.10. GE Healthcare
  • 12.11. GeneWiz Inc
  • 12.12. Illumina Inc
  • 12.13. Luminex Corporation
  • 12.14. Myriad Genetics
  • 12.15. Navigenics
  • 12.16. Pacific Biosciences
  • 12.17. Qiagen Inc
  • 12.18. Roche Diagnostics

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

13. Appendix

  • 13.1. Abbreviations
  • 13.2. Sources
  • 13.3. Research Methodology
  • 13.4. Bibliography
  • 13.5. Compilation of Expert Insights
  • 13.6. Disclaimer
Back to Top